Breaking Former Carolina Panthers Linebacker Thomas Davis Reveals Opioid Addiction Struggle Nurse Practitioner’s DEA Registration Revoked Amidst Allegations of Illegal Opioid Prescriptions Crown Prince Haakon Ascends to Norwegian Throne as King Haakon VIII AI Chatbots Emerge as New Spiritual Guides Amidst Growing Demand Los Angeles Rams Conclude Undefeated Preseason With Victory Over Chargers

Friday August 28, 2026

Reporter

Propanc Biopharma, Inc.

5Articles Published

4Communities Covered

Published Articles

Press Release

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit

Aug 27

Press Release

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

Aug 18

Press Release

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Aug 12

Press Release

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Aug 6

Press Release

Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program

Aug 5